3,4,5-tris(benzyloxy)-2-((benzyloxy)methyl)piperidine

Catalog No. :
ACYSBL843
CAS No. :
69567-11-9
Molecular Formula :
C34H37NO4
Molecular Weight :
523.67

IUPAC Name:3,4,5-tris(benzyloxy)-2-((benzyloxy)methyl)piperidine

3,4,5-tris(benzyloxy)-2-((benzyloxy)methyl)piperidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$572.00Login to see priceInquiryInquiry
250mg95%$1179.00Login to see priceInquiryInquiry
1g95%$2948.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3,4,5-tris(benzyloxy)-2-((benzyloxy)methyl)piperidine
IUPAC Name3,4,5-tris(benzyloxy)-2-((benzyloxy)methyl)piperidine
MDL No.MFCD11113146
Molecular FormulaC34H37NO4
Molecular Weight523.67
SMILESC1=CC=C(COCC2NCC(OCC3=CC=CC=C3)C(OCC3=CC=CC=C3)C2OCC2=CC=CC=C2)C=C1
InChI KeyHHIIDKLQTCPFQA-UHFFFAOYSA-N
SynonymDeoxynojirimycin Tetrabenzyl Ether;Deoxynojirimycin Tetrabenzyl Ether Exclusive;3,4,5-tris(benzyloxy)-2-((benzyloxy)methyl)piperidine;3,4,5-tris(benzyloxy)-2-((benzyloxy)methyl)piperidine(WXC06522);Piperidine,3,4,5-tris(phenylmethoxy)-2-[(phenylmethoxy)methyl]-,(2R,3R,4R,5S)-;2,3,4,6-Tetra-O-benzyl-(+)-1-deoxynojirimycin;Canagliflozin Impurity 126
CAS No.69567-11-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACYSBL843 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYSBL843 route product structure diagram
    ACYSBL84369567-11-9
Inquiry

2. ACYSBL843 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYSBL843 route product structure diagram
    ACYSBL84369567-11-9
Inquiry

Comments (0)